期刊文献+

曲安奈德术中眼内注射对血眼屏障的保护作用 被引量:8

Protective effect of triamcinolone acetonide on blood-ocular barrier in complicated vitreoretinal surgery.
暂未订购
导出
摘要 目的评价术中玻璃体腔内注射曲安奈德(triamcinolone acetonide)对复杂的玻璃体视网膜手术术后血眼屏障的保护作用.方法11例(13眼)复杂的玻璃体视网膜手术,手术结束后,将曲安奈德混悬液注入玻璃体腔内,在硅油填充眼,曲安奈德的注入量为0.05mL(2mg),非硅油填充眼为0.1mL(4mg).手术后随访2~4月,观察曲安奈德颗粒的消失时间、抗炎效果和并发症.结果曲安奈德颗粒从眼内消失的时间,硅油填充眼为2~3月,非硅油填充眼为1~1.5月.术后均未出现明显的早期眼部炎症反应.眼压升高2眼,1眼由硅油引起,另1眼发生在手术后4月,由葡萄膜炎引起.无与曲安奈德相关的并发症发生.结论对复杂的玻璃体视网膜手术,术中玻璃体腔内注射曲安奈德可有效地防止血眼屏障破坏,减轻手术后眼部炎症反应. Objective To evaluate the protective effect of triamcinolone acetonide (TA) on blood- ocular barrier in complicated vitreoretinal surgery by intravitreal injection. Methods After complicated vitreoretinal surgery, 0.05ml (2mg) TA suspension was injected into vitreous body in 9 silicone oil filled eyes and 0. lml (4mg) in 4 non- silicone oil filled eyes. The clearance time of TA, its anti - inflammation effect and complications were observed. The follow - up time was 2 - 4 months. Results The clearance time of TA in silicone filled eyes was 2 - 3 months and 1 - 1.5 months in non - silicone oil filled eyes. No obvious early postoperative inflammation took place in any eye. Intraocular pressure elevated in 2 eyes, 1 was induced by silicone oil and another by uveitis. No TA associated complications appeared. Conclusion For complicated vitreoretinal surgery, intravitreal TA injection can effectively protect the breakdown of blood - ocular barrier and decrease postoperative ocular inflammation.
出处 《眼外伤职业眼病杂志》 北大核心 2005年第9期653-656,共4页 Journal of Injuries and Occupational Diseases of the Eye with Ophthalmic Surgeries
关键词 曲安奈德 玻璃体视网膜手术 血眼屏障 triamcinolone acetonide vitreoretinal surgery blood- ocular barrier
  • 相关文献

参考文献18

  • 1Jonas JB. Concentration of intravitreally injected triamcinolone acetonide in aqueous humour[J]. Br J Ophthalmol, 2002,86(9): 1066.
  • 2Jonas JB. Concentration of intravitreally injected triamcinolone acetonide in intraocular silicone oil[J]. Br J Ophthalmol, 2002,86(12): 1450- 1451.
  • 3Holz FG; Spaide RF. Medical retina: Intravitreal injection of triamcinolone acetonide[M]. Springer: Heidelberg, 2005, 143- 164.
  • 4Hogan MJ, Kimura SJ, Thygeson P. Signs and symptoms of uveitis. I. Anterior uveitis[J]. Am J Ophthalmol, 1959,47(5): 155 - 170.
  • 5Lahey JM, Francis RR, Keamey JJ. Combining phacoemulsification with pars plana vitrectomy in patients with proliferative diabetic retinopathy: a series of 223 cases[J]. Ophthalmology, 2003,110(7): 1335 - 1339.
  • 6Schatz B, EI - Shabawi Y, Haas A,et al. Adverse side effects with perfluorohexyloctane as a long - term tamponade agent in complicated vitreoretinal surgery[J]. Retina, 2004,24(4) :567 - 573.
  • 7Kon CH, Asaria RH, Occleston NL, Khan PT, Aylward GW. Risk factors for proliferative vitreoretinopathy after primary vitrectomy: a prospective study[J]. Br J Ophthalmol, 2000,84:506 - 511.
  • 8Machmer R, Buettner H, Norton EW, et al. Vitrectomy: a pars plana approach[J]. Trans Am Acad Ophthalmol Otolaryngol, 1971,75(4):813-820.
  • 9Peyman GA, Dodich NA. Experimental vitrectomy. Instrumentation and surgical technique[J]. Arch Ophthalmol, 1971,86(5) :548 - 551.
  • 10Degenring R, Jonas JB. Serum levels of triamcinolone acetonide after intravitreal injection[J]. Am J Ophthalmol, 2004,137(6): 1142- 1143.

同被引文献55

引证文献8

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部